1 July 2018
Drug reviews and drug licensing
Showing results 31 - 40 of 100
Sorted by most recent
11 June 2018
11 June 2018
10 May 2018
10 May 2018
10 May 2018
6 April 2018
6 April 2018
5 March 2018
5 March 2018
Validation period: 10/3/2023, 12:37:45 AM - 10/10/2023, 12:37:45 AM
Ocrelizumab for multiple sclerosis What place is there for tramadol/dexketoprofen? What dose of paracetamol for older people? ▼ Bezlotoxumab for prevention of recurrence of Clostridium difficile infection Esmya (ulipristal acetate) - safety update ▼ Safinamide for Parkinson’s disease Once-daily triple therapy inhaler for COPD ▼ Daclizumab withdrawn from the market worldwide ▼Dupilumab for atopic dermatitis Drugs and their names